Fenofibrate Tablet
Product Images NDC 73352-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 73352-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Label (Label)
This is a description of a pharmaceutical product containing Fenofibrate USP 40mg tablets distributed by Tritlvent Pharma, LLC in San Antonio, Texas. The product is labeled as Trifluent Pharma. The package insert should be consulted for the correct dosage information and other prescribing details. It is advised to store the tablets at a temperature between 68°F and 77°F and to keep the medication out of reach of children. The medication should be dispensed in a tightly closed, light-resistant container with a child-resistant closure as per USP guidelines. The text also includes the NDC code, Rx only label, and a license number: MH/104129.*
FDA Label Image

Labels (Labels)

Labels (Labels)
This is a prescription medication for Fenofibrate tablets, USP. Each tablet contains 120 mg of Fenofibrate. The usual dosage information can be found in the package insert. It is recommended to store the medication in a cool place between 20° to 25°C (68° to 77°F). The medication should be kept out of reach of children and stored in a light-resistant container. This product is distributed by Trifluent Pharma, LLC.*
FDA Label Image

Image (Df24d655 6e41 4582 9f5e 771d36a79e7f 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.